NCT06240416

Brief Summary

The aim was to compare the osteoblast activity and osteogenic potential of autogenous bone particles harvested using three different techniques, determine the most advantageous method of collecting autogenous bone particles. Bone particles were harvested during dental implant surgery using low-speed drilling and high speed drilling. After the osteoblasts were cultured, cell proliferation, migration, mineralization, transcription of osteogenesis-related genes, secretion of osteogenesis-related proteins, and osteoinductive protein content in the bone particle matrix were evaluated

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 9, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

February 5, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

March 15, 2024

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2024

Completed
Last Updated

February 5, 2024

Status Verified

December 1, 2023

Enrollment Period

21 days

First QC Date

January 9, 2024

Last Update Submit

January 31, 2024

Conditions

Keywords

Dental implantsOsteotomyTemperatureHistology

Outcome Measures

Primary Outcomes (1)

  • Study of the size of bone particles collected during implant osteotomy, the presence or absence of collagen fibrils, and the levels of calcium and phosphorus in them.

    Once the amount of collected bone has been analyzed, 100 mg of bone will be used for the remaining study variables. The bone samples will be embedded in a 37% phosphoric acid gel for 15 seconds and then washed with plenty of water to remove the remaining acid. Subsequently, the samples will be mounted on holders for examination under the scanning electron microscope after receiving a carbon coating. After visualizing the samples at 100X, digital images will be taken for analysis using the image analysis software ImageJ. Finally, calcium and phosphorus levels will be analyzed using the Inca Microanalysis Systems software. The size will be expressed in nm.

    day 1

Secondary Outcomes (7)

  • Quantify BMP-2 and VEGF in the bone collected during implant osteotomy using conventional and low-speed milling.

    day 14

  • Analysis of the morphology and number of osteoblasts in the bone collected during implant osteotomy.

    day 14

  • Assessment of the presence of precipitated calcium nodules in the cell culture of osteoblasts after collecting bone during implant osteotomy.

    day 21

  • Study of cell viability (cell proliferation assay)

    day 12

  • Determination of the cell cycle (G0/G1, G2/M, and S)

    day 21

  • +2 more secondary outcomes

Study Arms (2)

Control group

EXPERIMENTAL

High speed drilling (800 rpm) with irrigation

Procedure: High speed drilling with irrigation

Test group

EXPERIMENTAL

Low speed drilling (50 rpm) without irrigation

Procedure: Low speed drilling without irrigation

Interventions

Low-speed drilling (50 rpm) irrigation to perform the osteotomy

Test group

High-speed drilling (800 rpm) irrigation to perform the osteotomy

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Legal age
  • Informed consent signed
  • Bilateral mandibular dental absence of 3.6 and 4.6 for more than 3 months
  • Normal bone density in the posterior mandibular sector with type II/III bone (range of 500-850 HU) according to the classification of Norton and Gamble
  • No medical contraindications for the performance of oral surgical procedures (ASA I/II).

You may not qualify if:

  • Presence of any disease, condition, or medication that may compromise the healing and/or osseointegration of dental implants (such as diabetes mellitus, bisphosphonate administration, or severe osteoporosis)
  • Presence of any severe mental disorder
  • Patients who have undergone head and neck radiotherapy in the previous 18 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Therapeutic Irrigation

Intervention Hierarchy (Ancestors)

HydrotherapyPhysical Therapy ModalitiesTherapeuticsRehabilitationInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A split mouth randomized clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2024

First Posted

February 5, 2024

Study Start

March 15, 2024

Primary Completion

April 5, 2024

Study Completion

April 5, 2024

Last Updated

February 5, 2024

Record last verified: 2023-12